Aging symptom trajectories in mother carriers of the FMR1 premutation

Active Project Grant Awarded Last action

Award ID
R01AG073374
Recipient
Awarding agency
Obligated
$10,011,476

Award facts

Assistance listing
93.866 Aging Research
Completion date 92% complete
Funding
  • $9,404,807.00 Federal
  • $606,669.00 Non-federal
Place of performance
Columbia, SC 29208, USA

Award details come from USAspending.gov.

Description

Abstract
About 1 in 151 women in the US are carriers of a genetic abnormality called the FMR1 premutation (FXPM). Mothers who carry the FXPM are at risk for passing the mutated gene to their children, which may result in fragile X syndrome. The FXPM is also associated with substantially increased risk for disease, including neurodegenerative disease, premature menopause, psychiatric involvement, and executive and social deficits. New evidence suggests that FXPM carrier mothers may experience premature age-related decline across multiple symptom domains. The aging expression of FXPM phenotype is particularly concerning when applied within the context of fragile X families because these symptoms impact not only the carrier mother, but also her ability to care and advocate for her children with fragile X syndrome. However, almost all evidence of age- related decline in this group has been gleaned from cross-sectional data that are insufficient for drawing robust longitudinal trajectories. This represents a substantial barrier to effective clinical management, as we lack the data needed to understand the long-term effects of the FXPM genotype and its implications for families. This proposal seeks to determine the stability of key FXPM phenotypes (mental health, executive, social) across midlife and early old age in FXPM carrier mothers compared to healthy controls (aim 1); investigate autonomic and molecular-genetic factors associated with age-related symptom expression and their interface with parenting stress (aim 2); and evaluate functional limitations associated with FXPM symptoms across age (aim 3). We will accomplish these aims by adopting an accelerated longitudinal design to track age-related change occurring across 45-80 years in 75 FXPM carrier mothers compared to 75 control mothers. The over- arching goal is to inform the critical age periods and risk factors in age-related decline, as well as to lay the groundwork for future mechanistic studies. This work is necessary to develop strategies to ameliorate FXPM symptoms, which will improve outcomes for both FXPM carrier mothers and their children with fragile X syndrome.

Transactions

Action Federal Non-federal Date
Amendment $562,780 $0
Amendment $45,866 $0
Amendment $45,866 $0
Amendment $104,209 $0
Amendment $104,209 $0
Amendment $515,968 $0
Amendment $515,968 $0
Amendment $10,826 $0
Amendment $10,826 $0
Amendment $577,224 $0
Amendment $577,224 $0
Amendment $577,224 $0
Amendment $10,826 $0
Amendment $10,826 $0
Amendment $10,826 $0
Amendment $395,485 $0
Amendment $395,485 $0
Amendment $395,485 $0
Amendment $395,485 $0
Amendment $580,548 $0
Amendment $580,548 $0
Amendment $580,548 $0
Amendment $580,548 $0
Amendment $606,669 $0
Amendment $606,669 $606,669
Original award $606,669 $0
Show all 26

Subawards

Subrecipient Amount Awarded
Rush University Medical Center Dr. Berry-Kravis, principal investigator for the Chicago (Rush University) site, will oversee the subcontract work and co-ordinate all aspects of this project… $35,267
Medical University Of South Carolina The This project will examine cognitive impairment profiles in women with the Fragile X Messenger Riboneucleoprotein-1 (FMR1) premutation (FXpm). The MUSC site… $23,352
Subrecipient not on record This proposal seeks to determine the stability of core FMR1 premutation symptoms (mental health, executive, social) across middle adulthood and early old age in… $33,190
Rush University Medical Center Dr. Berry-Kravis, principal investigator for the Chicago (Rush University) site, will oversee the subcontract work and co-ordinate all aspects of this project… $35,267
University Of Wisconsin System Dr. Marsha Mailick of the University of Wisconsin- Madison will provide scientific expertise on the age-related behavioral phenotype of the FMRI premutation.… $29,872

Quick answers

Who received award R01AG073374?

R01AG073374 was awarded to University Of South Carolina by National Institute on Aging (National Institutes of Health) on July 15, 2022.

How much is award R01AG073374 worth?

$10,011,476 has been obligated on R01AG073374: $9,404,807 in federal funding and $606,669 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award